Results 321 to 330 of about 510,697 (405)

A matter arising: When should inflammatory and autoimmune rheumatic diseases be considered ‘early’?

European Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
Timely recognition of inflammatory and autoimmune rheumatic diseases (IARDs) is important to optimize the early diagnosis with tailored interventions and possible prevention of irreversible organ damage. This narrative review provides an update by summarizing the advances in identifying the early stages of rheumatoid arthritis, systemic sclerosis and ...
Elvis Hysa, Emanuele Gotelli, Carmen Pizzorni, Sabrina Paolino, Alberto Sulli, Vanessa Smith, Rosanna Campitiello, Maurizio Cutolo   +7 more
wiley   +1 more source

Antisynthetase Syndrome Masquerading As Psoriasis and Psoriatic Arthritis: A Case Report. [PDF]

Cureus
Chow EY, Tran KH, Lai R.
europepmc   +1 more source

Reduced EZH2 Expression in Circulating CD8‐Positive T Cells and Monocytes in Psoriasis

Experimental Dermatology, Volume 35, Issue 1, January 2026.
ABSTRACT Enhancer of Zeste Homologue 2 (EZH2) is an epigenetic regulator involved in immune cell differentiation and function; however, its role in psoriasis remains unknown. This study aimed to evaluate EZH2 expression in peripheral blood mononuclear cells from patients with psoriasis and explore its potential functional relevance to disease ...
Toyoki Yamamoto, Rino Toyoshima, Lixin Li, Asumi Koyama, Shinichi Sato, Sayaka Shibata   +5 more
wiley   +1 more source

Dual biologic therapy in a patient with severe psoriasis and psoriatic arthritis, using guselkumab and bimekizumab: A case report and review of the literature. [PDF]

SAGE Open Med Case Rep
Muylaert Barrett B, Music M, Yadav G.
europepmc   +1 more source

What Is the Diagnostic Capacity of Existing Severity Scoring Tools for Nail Psoriasis?

International Journal of Dermatology, Volume 65, Issue 1, Page 86-92, January 2026.
ABSTRACT Background It is challenging to distinguish nail psoriasis (NP) from nonspecific nail changes, contributing to heterogeneity in clinical trials. Existing scoring tools for NP are currently used to assess severity after diagnosis is established.
Evi C. C. Rikken, Tamara W. van Hal, Juul M. P. A. van den Reek, Karlijn M. G. Klaassen, Elke M. G. J. de Jong, Marcel C. Pasch   +5 more
wiley   +1 more source

Dual-platform urinary metabolomics identifies candidate diagnostic biomarkers in Psoriatic Arthritis. [PDF]

Biochem Biophys Rep
Peddi K, Cheekatla SS, Davulury U, Ushus Mj P, Mutyam S, Kumar Kandula S, Kolukula NR, Reddy Munagala VV, Vallabhapurapu S.   +8 more
europepmc   +1 more source

Disease Modification of Pustular Psoriasis by Secukinumab: A 20‐Year Follow‐Up of Von Zumbusch‐Type Generalized Pustular Psoriasis With Evolution Into Annular Pustular Psoriasis—A Case Report

The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 1, January 2026.
Yu‐Han Alice Hsu, Cheng‐Che E. Lan, Sheng‐Yiao Lin   +2 more
wiley   +1 more source

Mitochondrial Activity Regulates Human T Helper 17 Differentiation and Function

Immunology, Volume 177, Issue 1, Page 185-198, January 2026.
Naïve CD4+ T cells differentiating into RORγt+IL‐17A+ Th17 cells are characterised by a shift from glycolysis to oxidative phosphorylation. Early‐stage cells favour glycolysis, whereas later‐stage cells with hyperpolarised mitochondrial membrane potential (ΔΨ) rely more on oxidative phosphorylation, show increased activation, and differentiate more ...
Xinlai Chen, Theodoros Ioannis Papadimitriou, Anne H. G. van Essen, Britt van Brunschot, Monique M. Helsen, Annet Sloetjes, Elly L. Vitters, Werner J. H. Koopman, Peter M. van der Kraan, Arjan P. M. van Caam, Marije I. Koenders   +10 more
wiley   +1 more source

Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study. [PDF]

Rheumatology (Oxford)
López-Medina C, Gorlier C, Orbai AM, Coates LC, Kiltz U, Leung YY, Palominos P, Cañete JD, Cañete JD, Scrivo R, Balanescu A, Dernis E, Meisalu S, Ruyssen-Witrand A, Soubrier M, Aydin SZ, Eder L, Gaydukova I, Lubrano E, Kalyoncu U, Richette P, Husni ME, Smolen JS, de Wit M, Gossec L.   +24 more
europepmc   +1 more source

The comparative prevalence of comorbidities across rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis. [PDF]

Rheumatol Adv Pract
Williams JC, Southworth J, Rogers K, Zhao SS.   +3 more
europepmc   +1 more source